At its October 2020 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the 2021 Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger. After Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration (FDA), ACIP issued an interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years at its December 12, 2020, meeting (1). In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent immunization schedule. After Emergency Use Authorization of Moderna COVID-19 vaccine by FDA, ACIP issued an interim recommendation for use of Moderna COVID-19 vaccine in persons aged ≥18 years at its December 19, 2020, emergency meeting (2).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877586PMC
http://dx.doi.org/10.15585/mmwr.mm7006a1DOI Listing

Publication Analysis

Top Keywords

covid-19 vaccine
20
immunization schedule
12
advisory committee
8
committee immunization
8
years younger
8
2020 meeting
8
acip approved
8
child adolescent
8
adolescent immunization
8
emergency authorization
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!